-+ 0.00%
-+ 0.00%
-+ 0.00%
AcuCort Files New Drug Application for Zeqmelit in US
Share
Listen to the news
05:23 AM EST, 11/16/2026 (MT Newswires) -- AcuCort (ACUC.ST) filed its new drug application to secure Zeqmelit's marketing authorization in the US, according to a Monday release. The application expects to receive the US Food and Drug Administration's approval in the second half of 2027. The pharmaceutical group added that it plans to commercially launch Zeqmelit in the first half of 2028.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending